Healthcare
Perrigo Company plc(PRGO)
Live Price
Offline$10.25
+0.89% today
1Y Change
-61.25%
Window
Jun 23, 2025 โ Jun 18, 2026
- Market Cap
- $1.64B
- Revenue Growth
- -2.8%
- EPS Growth
- -723.2%
- Dividend Yield
- 9.7%
Coverage: 249 bars ยท Jun 23, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Perrigo Company plc (PRGO) is a Healthcare stock with a market cap of $1.64B and listed on NYSE. The stock last traded around $10.25 and down 61.2% across the available one-year price window (Jun 23, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of -2.8%, EPS growth of -723.2%, a dividend yield of 9.7%. What stands out right now is revenue -2.8%, EPS -723.2%, free cash flow -40.7% with operating margin 5.9% and ROIC 3.3%. The dividend matters to the case here, with a current yield around 9.7%. Valuation is more restrained than many high-expectation growth names at price/sales 0.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PRGO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-2.8% vs +7.6% peer median
Operating Margin
Below sector median
+5.9% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 6, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -2.8% and EPS is at -723.2%, with operating margin around 5.9%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 9.7%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -12.8% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 6, 2026 | โ | -4.4% | -11.0% | -13.0% |
2026 Feb 26, 2026 | -3.8% | -6.8% | -21.1% | -33.9% |
2025 Nov 5, 2025 | +6.7% | -1.1% | -6.2% | -10.7% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PRGO
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
PRGO Max Drawdown
-67.46%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for PRGO and SPY.
Company Overview
Perrigo Company plc
New York Stock Exchange
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
- Leadership
- Patrick Lockwood-Taylor
- IPO Date
- Dec 17, 1991
- Employees
- 8.4k
- Street Address
- The Sharp Building
- Mailing
- Dublin, 2
- Region
- Dublin, IE
- Reporting Currency
- USD
- Investor Line
- 353 1 709 4000
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.4
- Price/Book
- 0.6
Growth
- Revenue
- -2.8%
- EPS
- -723.2%
- Free Cash Flow
- -40.7%
Profitability
- Gross Margin
- 35.1%
- Operating Margin
- 5.9%
- Net Margin
- -33.5%
- ROE
- -35.2%
- ROIC
- 3.3%
Balance Sheet
- Debt/Equity
- 1.35
- Current Ratio
- 2.76
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.